Works in European Journal of Nuclear Medicine & Molecular Imaging, 2022, Vol 49, Issue 6

Results: 32

Correction to: Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers.

Published in:

2022

By:

Stormezand, Gilles N.;
Doorduin, Janine;
Rakers, Sandra E.;
Spikman, Jacoba M.;
van der Naalt, Joukje;
García, David Vállez;
van der Hoorn, Anouk;
van der Weijden, Chris W. J.;
Kremer, Berry P. H.;
Renken, Remco J.;
Dierckx, Rudi A. J. O.

Publication type:

Correction Notice

Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond.

Published in:

2022

By:

Younis, Muhsin H.;
Malih, Sara;
Lan, Xiaoli;
Rasaee, Mohammad Javad;
Cai, Weibo

Publication type:

Editorial

Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.

Published in:

2022

By:

Laudicella, R.;
Quartuccio, N.;
Argiroffi, G.;
Alongi, P.;
Baratto, L.;
Califaretti, E.;
Frantellizzi, V.;
De Vincentis, G.;
Del Sole, A.;
Evangelista, L.;
Baldari, S.;
Bisdas, S.;
Ceci, Francesco;
Iagaru, Andrei

Publication type:

Correction Notice

Correction to: EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3.

Published in:

2022

By:

Guedj, Eric;
Varrone, Andrea;
Boellaard, Ronald;
Albert, Nathalie L.;
Barthel, Henryk;
van Berckel, Bart;
Brendel, Matthias;
Cecchin, Diego;
Ekmekcioglu, Ozgul;
Garibotto, Valentina;
Lammertsma, Adriaan A.;
Law, Ian;
Peñuelas, Iván;
Semah, Franck;
Traub-Weidinger, Tatjana;
van de Giessen, Elsmarieke;
Van Weehaeghe, Donatienne;
Morbelli, Silvia

Publication type:

Correction Notice

Correction to: [89Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.

Published in:

2022

By:

Krebs, Simone;
Grommes, Christian;
McDevitt, Michael R.;
Carlin, Sean D.;
O'Donoghue, Joseph A.;
Graham, Maya S.;
Young, Robert J.;
Schöder, Heiko;
Gutin, Philip H.;
Bander, Neil H.;
Osborne, Joseph R.

Publication type:

Correction Notice

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1778, doi. 10.1007/s00259-022-05727-7

By:

Sjögreen Gleisner, Katarina;
Chouin, Nicolas;
Gabina, Pablo Minguez;
Cicone, Francesco;
Gnesin, Silvano;
Stokke, Caroline;
Konijnenberg, Mark;
Cremonesi, Marta;
Verburg, Frederik A.;
Bernhardt, Peter;
Eberlein, Uta;
Gear, Jonathan

Publication type:

Article

Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1810, doi. 10.1007/s00259-021-05670-z

By:

Liu, Tianyu;
Wu, Yue;
Shi, Linqing;
Li, Liqiang;
Hu, Biao;
Wang, Yanpu;
Gao, Hannan;
Yu, Xiaolu;
Zhang, Xin;
Zhao, Huiyun;
Wan, Yakun;
Jia, Bing;
Wang, Fan

Publication type:

Article

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1951, doi. 10.1007/s00259-021-05669-6

By:

Visser, Denise;
Verfaillie, Sander C. J.;
Wolters, Emma E.;
Coomans, Emma M.;
Timmers, Tessa;
Tuncel, Hayel;
Boellaard, Ronald;
Golla, Sandeep S. V.;
Windhorst, Albert D.;
Scheltens, Philip;
van der Flier, Wiesje M.;
van Berckel, Bart N. M.;
Ossenkoppele, Rik

Publication type:

Article

Prediction of myocardial blood flow under stress conditions by means of a computational model.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1894, doi. 10.1007/s00259-021-05667-8

By:

Di Gregorio, Simone;
Vergara, Christian;
Pelagi, Giovanni Montino;
Baggiano, Andrea;
Zunino, Paolo;
Guglielmo, Marco;
Fusini, Laura;
Muscogiuri, Giuseppe;
Rossi, Alexia;
Rabbat, Mark G.;
Quarteroni, Alfio;
Pontone, Gianluca

Publication type:

Article

Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1939, doi. 10.1007/s00259-021-05666-9

By:

Morbelli, Silvia;
Chiola, Silvia;
Donegani, Maria Isabella;
Arnaldi, Dario;
Pardini, Matteo;
Mancini, Raffaele;
Lanfranchi, Francesco;
D'amico, Francesca;
Bauckneht, Matteo;
Miceli, Alberto;
Biassoni, Erica;
Orso, Beatrice;
Barisione, Emanuela;
Benedetti, Luana;
Gianmario, Sambuceti;
Nobili, Flavio

Publication type:

Article

68Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2096, doi. 10.1007/s00259-021-05664-x

By:

Shang, Qihang;
Hao, Bing;
Xu, Weizhi;
Meng, Tinghua;
Pang, Yizhen;
Sun, Long;
Chen, Haojun

Publication type:

Article

Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1906, doi. 10.1007/s00259-021-05663-y

By:

Tamaki, Shunsuke;
Yamada, Takahisa;
Watanabe, Tetsuya;
Morita, Takashi;
Kawasaki, Masato;
Kikuchi, Atsushi;
Kawai, Tsutomu;
Seo, Masahiro;
Nakamura, Jun;
Kayama, Kiyomi;
Sakamoto, Daisuke;
Ueda, Kumpei;
Kogame, Takehiro;
Tamura, Yuto;
Fujita, Takeshi;
Nishigaki, Keisuke;
Fukuda, Yuto;
Kokubu, Yuki;
Fukunami, Masatake

Publication type:

Article

89Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2064, doi. 10.1007/s00259-021-05661-0

By:

Privé, Bastiaan M.;
Derks, Yvonne H. W.;
Rosar, Florian;
Franssen, Gerben M.;
Peters, Steffie M. B.;
Khreish, Fadi;
Bartholomä, Mark;
Maus, Stephan;
Gotthardt, Martin;
Laverman, Peter;
Konijnenberg, Mark W.;
Ezziddin, Samer;
Nagarajah, James;
Heskamp, Sandra

Publication type:

Article

Determination of optimal 68 Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2086, doi. 10.1007/s00259-021-05659-8

By:

Wen, Jun;
Zhu, Yinjie;
Li, Lianghua;
Liu, Jianjun;
Chen, Yumei;
Chen, Ruohua

Publication type:

Article

Morphometric analysis program and quantitative positron emission tomography in presurgical localization in MRI-negative epilepsies: a simultaneous PET/MRI study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1930, doi. 10.1007/s00259-021-05657-w

By:

Guo, Kun;
Wang, Jingjuan;
Wang, Zhenming;
Wang, Yihe;
Cui, Bixiao;
Zhao, Guoguang;
Lu, Jie

Publication type:

Article

[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2037, doi. 10.1007/s00259-021-05656-x

By:

Spada, Francesca;
Campana, Davide;
Lamberti, Giuseppe;
Laudicella, Riccardo;
Dellamano, Renato;
Dellamano, Luca;
Leeuwenkamp, Oscar;
Baldari, Sergio

Publication type:

Article

Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2077, doi. 10.1007/s00259-021-05655-y

By:

Kesler, Mikhail;
Kerzhner, Kosta;
Druckmann, Ido;
Kuten, Jonathan;
Levine, Charles;
Sarid, David;
Keizman, Daniel;
Yossepowitch, Ofer;
Even-Sapir, Einat

Publication type:

Article

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [68Ga]Ga-OncoFAP-DOTAGA.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1822, doi. 10.1007/s00259-021-05653-0

By:

Backhaus, P.;
Gierse, F.;
Burg, M. C.;
Büther, F.;
Asmus, I.;
Dorten, P.;
Cufe, J.;
Roll, W.;
Neri, D.;
Cazzamalli, S.;
Millul, J.;
Mock, J.;
Galbiati, A.;
Zana, A.;
Schäfers, K. P.;
Hermann, S.;
Weckesser, M.;
Tio, J.;
Wagner, S.;
Breyholz, H.-J.

Publication type:

Article

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1857, doi. 10.1007/s00259-021-05650-3

By:

Hribernik, Nežka;
Huff, Daniel T;
Studen, Andrej;
Zevnik, Katarina;
Klaneček, Žan;
Emamekhoo, Hamid;
Škalic, Katja;
Jeraj, Robert;
Reberšek, Martina

Publication type:

Article

Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1918, doi. 10.1007/s00259-021-05649-w

By:

Yin, Yafu;
Wu, Jing;
Wu, Shuqi;
Chen, Suyun;
Cheng, Weiwei;
Li, Ling;
Wang, Hui

Publication type:

Article

13 N-ammonia PET-derived right ventricular longitudinal strain and myocardial flow reserve in right coronary artery disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1870, doi. 10.1007/s00259-021-05647-y

By:

Kawakubo, Masateru;
Nagao, Michinobu;
Yamamoto, Atsushi;
Nakao, Risako;
Matsuo, Yuka;
Kaneko, Koichiro;
Watanabe, Eri;
Sakai, Akiko;
Sasaki, Masayuki;
Sakai, Shuji

Publication type:

Article

Within-patient comparison between [68Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [99mTc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2023, doi. 10.1007/s00259-021-05645-0

By:

Mahieu, Rutger;
Donders, Dominique N. V.;
Krijger, Gerard C.;
Ververs, F. F. Tessa;
de Roos, Remmert;
Bemelmans, John L. M. M.;
van Rooij, Rob;
de Bree, Remco;
de Keizer, Bart

Publication type:

Article

A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1843, doi. 10.1007/s00259-021-05644-1

By:

Xue, Song;
Guo, Rui;
Bohn, Karl Peter;
Matzke, Jared;
Viscione, Marco;
Alberts, Ian;
Meng, Hongping;
Sun, Chenwei;
Zhang, Miao;
Zhang, Min;
Sznitman, Raphael;
El Fakhri, Georges;
Rominger, Axel;
Li, Biao;
Shi, Kuangyu

Publication type:

Article

Improved myocardial blood flow estimation with residual activity correction and motion correction in 18F-flurpiridaz PET myocardial perfusion imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1881, doi. 10.1007/s00259-021-05643-2

By:

Otaki, Yuka;
Van Kriekinge, Serge D.;
Wei, Chih-Chun;
Kavanagh, Paul;
Singh, Ananya;
Parekh, Tejas;
Di Carli, Marcelo;
Maddahi, Jamshid;
Sitek, Arkadiusz;
Buckley, Christopher;
Berman, Daniel S.;
Slomka, Piotr J.

Publication type:

Article

PET imaging of metastatic paraganglioma using novel 3-[18F]fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) radiotracer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2098, doi. 10.1007/s00259-021-05639-y

By:

Wong, Ka Kit;
Else, Tobias;
Viglianti, Benjamin L.;
Brooks, Allen F.;
Frey, Kirk A.;
Raffel, David M.

Publication type:

Article

Comparison of deep learning-based emission-only attenuation correction methods for positron emission tomography.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1833, doi. 10.1007/s00259-021-05637-0

By:

Hwang, Donghwi;
Kang, Seung Kwan;
Kim, Kyeong Yun;
Choi, Hongyoon;
Lee, Jae Sung

Publication type:

Article

The effect of modern PET technology and techniques on the EANM paediatric dosage card.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1964, doi. 10.1007/s00259-021-05635-2

By:

Dickson, John;
Eberlein, Uta;
Lassmann, Michael

Publication type:

Article

[18F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1970, doi. 10.1007/s00259-021-05627-2

By:

de Koster, Elizabeth J.;
de Geus-Oei, Lioe-Fee;
Brouwers, Adrienne H.;
van Dam, Eveline W. C. M.;
Dijkhorst-Oei, Lioe-Ting;
van Engen-van Grunsven, Adriana C. H.;
van den Hout, Wilbert B.;
Klooker, Tamira K.;
Netea-Maier, Romana T.;
Snel, Marieke;
Oyen, Wim J. G.;
Vriens, Dennis

Publication type:

Article

First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1997, doi. 10.1007/s00259-021-05623-6

By:

Sari, Hasan;
Mingels, Clemens;
Alberts, Ian;
Hu, Jicun;
Buesser, Dorothee;
Shah, Vijay;
Schepers, Robin;
Caluori, Patrik;
Panin, Vladimir;
Conti, Maurizio;
Afshar-Oromieh, Ali;
Shi, Kuangyu;
Eriksson, Lars;
Rominger, Axel;
Cumming, Paul

Publication type:

Article

[18F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2010, doi. 10.1007/s00259-021-05610-x

By:

Vos, Joris L.;
Zuur, Charlotte L.;
Smit, Laura A.;
de Boer, Jan Paul;
Al-Mamgani, Abrahim;
van den Brekel, Michiel W. M.;
Haanen, John B. A. G.;
Vogel, Wouter V.

Publication type:

Article

Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 1985, doi. 10.1007/s00259-021-05591-x

By:

Zhang, Pu;
Xu, Mengxin;
Ding, Jie;
Chen, Junyi;
Zhang, Taiping;
Huo, Li;
Liu, Zhibo

Publication type:

Article

Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 6, p. 2049, doi. 10.1007/s00259-021-05582-y

By:

Fang, Hsin-Yu;
Stangl, Stefan;
Marcazzan, Sabrina;
Carvalho, Marcos J. Braz;
Baumeister, Theresa;
Anand, Akanksha;
Strangmann, Julia;
Huspenina, Julia Slotta;
Wang, Timothy C.;
Schmid, Roland M.;
Feith, Marcus;
Friess, Helmut;
Ntziachristos, Vasilis;
Multhoff, Gabriele;
Gorpas, Dimitris;
Quante, Michael

Publication type:

Article

Works in European Journal of Nuclear Medicine & Molecular Imaging, 2022, Vol 49, Issue 6

Correction to: Imaging of neuroinflammation due to repetitive head injury in currently active kickboxers.

Enhancing fibroblast activation protein (FAP)-targeted radionuclide therapy with albumin binding, and beyond.

Correction to: Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas.

Correction to: EANM procedure guidelines for brain PET imaging using [<sup>18</sup>F]FDG, version 3.

Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendroglioma.

EANM dosimetry committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands.

Preclinical evaluation of [<sup>99m</sup>Tc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT.

Differential associations between neocortical tau pathology and blood flow with cognitive deficits in early-onset vs late-onset Alzheimer's disease.

Prediction of myocardial blood flow under stress conditions by means of a computational model.

Metabolic correlates of olfactory dysfunction in COVID-19 and Parkinson's disease (PD) do not overlap.

<sup>68</sup>Ga-FAPI PET/CT detected non-FDG-avid bone metastases in breast cancer.

Usefulness of the 2-year iodine-123 metaiodobenzylguanidine-based risk model for post-discharge risk stratification of patients with acute decompensated heart failure.

<sup>89</sup>Zr-labeled PSMA ligands for pharmacokinetic PET imaging and dosimetry of PSMA-617 and PSMA-I&T: a preclinical evaluation and first in man.

Determination of optimal <sup>68</sup> Ga-PSMA PET/CT imaging time in prostate cancers by total-body dynamic PET/CT.

Morphometric analysis program and quantitative positron emission tomography in presurgical localization in MRI-negative epilepsies: a simultaneous PET/MRI study.

[<sup>177</sup>Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective.

Staging <sup>68</sup> Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.

Translational imaging of the fibroblast activation protein (FAP) using the new ligand [<sup>68</sup>Ga]Ga-OncoFAP-DOTAGA.

Quantitative imaging biomarkers of immune-related adverse events in immune-checkpoint blockade-treated metastatic melanoma patients: a pilot study.

Usefulness of brain FDG PET/CT imaging in pediatric patients with suspected autoimmune encephalitis from a prospective study.

<sup>13</sup> N-ammonia PET-derived right ventricular longitudinal strain and myocardial flow reserve in right coronary artery disease.

Within-patient comparison between [<sup>68</sup>Ga]Ga-tilmanocept PET/CT lymphoscintigraphy and [<sup>99m</sup>Tc]Tc-tilmanocept lymphoscintigraphy for sentinel lymph node detection in oral cancer: a pilot study.

A cross-scanner and cross-tracer deep learning method for the recovery of standard-dose imaging quality from low-dose PET.

Improved myocardial blood flow estimation with residual activity correction and motion correction in <sup>18</sup>F-flurpiridaz PET myocardial perfusion imaging.

PET imaging of metastatic paraganglioma using novel 3-[<sup>18</sup>F]fluoro-para-hydroxyphenethylguanidine (3-[<sup>18</sup>F]pHPG) radiotracer.

Comparison of deep learning-based emission-only attenuation correction methods for positron emission tomography.

The effect of modern PET technology and techniques on the EANM paediatric dosage card.

[<sup>18</sup>F]FDG-PET/CT to prevent futile surgery in indeterminate thyroid nodules: a blinded, randomised controlled multicentre trial.

First results on kinetic modelling and parametric imaging of dynamic <sup>18</sup>F-FDG datasets from a long axial FOV PET scanner in oncological patients.

[<sup>18</sup>F]FDG-PET accurately identifies pathological response early upon neoadjuvant immune checkpoint blockade in head and neck squamous cell carcinoma.

Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.

Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett's esophagus.